Yee

Spritzer EcoPark Taiping Brightens up the Sky with an Enchanting Aurora Light Show at Food, Arts and Music Carnival

Retrieved on: 
Mittwoch, Mai 8, 2024
Yee, Imagination, Internet, Heart, YB, Tourism, Foodie, Investment, Food, Economic development, Music, STG, Miniature, Symbiosis

Carnival delivers a whirlwind of activities from 27th April to 1st May 2024, running daily from 1:00pm to 12:00am.

Key Points: 
  • Carnival delivers a whirlwind of activities from 27th April to 1st May 2024, running daily from 1:00pm to 12:00am.
  • At the heart of this extravaganza lies the breathtaking Aurora Light Show, illuminating the skies of Taiping each night with dazzling moving streams, ripples, to arcs of colours, leaving attendees mesmerized.
  • Throughout the carnival, visitors can add a splash of fun to their carnival day at the daily foam party experience.
  • Winnie Chin, Spritzer's Head of Public Relations, shared, "Taiping, the Home of Spritzer, holds a special place in our hearts.

Yee Hop Holdings' (1662.HK) Subsidiary APEL Triumphs with Three Medals at the International Exhibition of Inventions Geneva

Retrieved on: 
Montag, Mai 6, 2024
Yee, Hydrogen, Cosmetics, Death, Innovation, Partnership, Water, Life, Invention, Spore, Virus, Environment, APEL, Hydrogen sulfide, Inhalation, Skin, Exhibition, Sustainability, Disinfectant, Smell, Attention, Gold, SGS, Pharmacy, Pet, Safety, Certification, Health, Bacteria, Research, Transport, Carbon, HKUST, Food industry, Human, Translation, Government, Drainage, Division, HKSAR, Sale, Biomedical technology, Biological engineering, Bed, Science park, Hong Kong Technology Venture, Injury, Convention center, HKSTP, Vacuum, New Territories, Fatality, QPP, Translational research, Growth, World's fair, Sewage treatment

APEL performed excellently at the 49th International Exhibition of Inventions Geneva, with three scientific research entries respectively winning two gold and one bronze medals, achieving a 100% success rate.

Key Points: 
  • APEL performed excellently at the 49th International Exhibition of Inventions Geneva, with three scientific research entries respectively winning two gold and one bronze medals, achieving a 100% success rate.
  • This exhibition is one of the largest international exhibitions of inventions, providing inventors and researchers with a unique opportunity to showcase research results and new products.
  • The 49th International Exhibition of Inventions Geneva was held in April in Geneva, Switzerland, featuring over 1,000 inventions from 38 countries and regions.
  • Today, we are delighted to receive recognition from international research institutions and achieve remarkable results at the International Exhibition of Inventions Geneva.

DXP Enterprises, Inc. Reports First Quarter 2024 Results

Retrieved on: 
Mittwoch, Mai 8, 2024
Chemicals, Plastics, Logistics, Supply Chain Management, Manufacturing, Nuclear, Food, Beverage, Commercial Building & Real Estate, Construction & Property, Retail, Other Transport, Other Energy, Utilities, Oil, Gas, Machinery, Coal, Alternative Energy, Transport, Energy, Mining, Minerals, Forest Products, Agriculture, Natural Resources, Yee, Central Time, Growth, DXP, Public expenditure, Senior, DXPE, Acquisition, Adjustment, The Company, Video game

DXP Enterprises, Inc. ("DXP" or the "Company") (NASDAQ: DXPE) today announced financial results for the first quarter ended March 31, 2024.

Key Points: 
  • DXP Enterprises, Inc. ("DXP" or the "Company") (NASDAQ: DXPE) today announced financial results for the first quarter ended March 31, 2024.
  • First Quarter 2024 Financial Highlights:
    Sales increased 1.4 percent sequentially to $412.6 million, compared to $407.0 million for the fourth quarter of 2023 and decreased 2.7 percent compared to $424.3 million for the first quarter of 2023.
  • Net income for the first quarter of 2024 was $11.3 million, compared to $17.6 million for the first quarter of 2023.
  • Adjusted EBITDA for the first quarter of 2024 was $40.3 million compared to $43.1 million for the first quarter of 2023.

Spartan Capital Securities Announces Successful Closing of Junee Limited’s $8 Million Initial Public Offering

Retrieved on: 
Donnerstag, April 18, 2024
Yee, LLP, Offering, Growth, Cryptocurrency

New York, NY , April 18, 2024 (GLOBE NEWSWIRE) -- Spartan Capital Securities LLC, a premier investment banking firm, is thrilled to announce the successful closing of Junee Limited’s initial public offering (the “Offering”) on April 19, 2024.

Key Points: 
  • New York, NY , April 18, 2024 (GLOBE NEWSWIRE) -- Spartan Capital Securities LLC, a premier investment banking firm, is thrilled to announce the successful closing of Junee Limited’s initial public offering (the “Offering”) on April 19, 2024.
  • The Offering was conducted on a firm commitment basis, with Spartan Capital Securities LLC serving as the sole book runner and lead underwriter.
  • Hunter Taubman Fischer & Li LLC acted as U.S. securities counsel to Junee, and FisherBroyles, LLP served as U.S. counsel to Spartan Capital Securities LLC in connection with the Offering.
  • John Lowry, CEO of Spartan Capital Securities LLC, expressed his delight, stating, “We are delighted to have played a pivotal role in facilitating Junee Limited’s successful initial public offering.

MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement

Retrieved on: 
Dienstag, April 30, 2024
Biotechnology, Pharmaceutical, Health, Oncology, Yee, Internal audit, HSBC, Market, Cancer, Security (finance)

MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that independent director Ms. Adelina Louie Ngar Yee made an individual purchase of 19,665 shares, and warrants for 19,665 shares, of MAIA’s common stock as part of the Company’s recent private placement of common stock and warrants to accredited investors and certain Company directors.

Key Points: 
  • MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that independent director Ms. Adelina Louie Ngar Yee made an individual purchase of 19,665 shares, and warrants for 19,665 shares, of MAIA’s common stock as part of the Company’s recent private placement of common stock and warrants to accredited investors and certain Company directors.
  • The securities sold to the Company directors participating in the offering were issued pursuant to the Company’s 2021 Equity Incentive Plan.
  • Ms. Louie has 30 years of service with HSBC Group in a variety of functions, principally with businesses of Global Banking and Markets including investment and securities management, asset management, and global research.
  • Most recently she was the Chief Operating Officer of Internal Audit at HSBC Group.

ACEN and Rockefeller Foundation Pilot Could Avoid up to 19 Million Tons of CO2 via Carbon Financing

Retrieved on: 
Mittwoch, April 17, 2024
Yee, Project, MAS, Climate change, Coal, CFPP, CCCI, Carbon dioxide, Climate, Rockefeller Foundation, Partnership, PDD, Electricity, Conference, Carbon, Wind, Retirement, RMI, COP28, Verra, CO2, Money, ACEN, SLTEC, Renewable energy

SINGAPORE, April 17, 2024 /PRNewswire/ -- ACEN Corporation and The Rockefeller Foundation announced today that the first Coal to Clean Credit Initiative (CCCI) pilot project under consideration in the Philippines could avoid up to 19 million tons of carbon dioxide (CO2) emissions. An RMI-led assessment supported by The Rockefeller Foundation explored the climate impact of leveraging carbon finance to close South Luzon Thermal Energy Corporation (SLTEC) coal plant in 2030 – ten years ahead of its scheduled retirement – and replacing it with clean power and battery storage, while supporting the livelihoods of workers affected by the plant's early transition.

Key Points: 
  • Announced during Financing Asia's Transition Conference, the analysis applied CCCI's draft methodology, currently under review by Verra, to assess SLTEC's eligibility for carbon financing.
  • Eric Francia, President & CEO of ACEN Corporation, said: "We are delighted to accomplish this important milestone of confirming the project's eligibility under CCCI's draft methodology.
  • This paves the way to fully develop the just transition plan and engage with potential buyers of carbon credits.
  • By 2025, ACEN hopes to finalize buyer discussions and reach a financial close for this world's first coal-to-clean carbon credit transaction.

MCCAIN FOODS CANADA HITS A GRAND SLAM: LOCKS DOWN THREE-YEAR PARTNERSHIP WITH TORONTO BLUE JAYS

Retrieved on: 
Freitag, April 12, 2024
Yee, Toronto Blue Jays, Cheese, Social media, Marketing, Partnership, BBQ, Friends, Family, Blue Jay, Butter, The Blue Jays, Rogers Centre

TORONTO, April 12, 2024 /CNW/ - McCain Foods Canada ("McCain"), the world's largest manufacturer of prepared potato products, has signed a three-year partnership agreement with the Toronto Blue Jays.

Key Points: 
  • TORONTO, April 12, 2024 /CNW/ - McCain Foods Canada ("McCain"), the world's largest manufacturer of prepared potato products, has signed a three-year partnership agreement with the Toronto Blue Jays.
  • As part of the partnership, the Blue Jays and McCain are inviting Canadians to Make It A Fry Day with their family and friends during Fry Days with McCain at the ballpark.
  • "We are thrilled to partner with McCain, a brand that shares our passion for excellence and innovation," said David O'Reilly, Director of Partnership Development, Toronto Blue Jays.
  • Joining forces with the Toronto Blue Jays is a testament to our dedication to Canadians, community, and togetherness," says Mike Embir, Marketing Director at McCain Foods Canada.

Avantor Wins Five Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2024

Retrieved on: 
Donnerstag, März 21, 2024
Yee, Organization, Growth, ABEA, Management

SINGAPORE, Mar 21, 2024 - (ACN Newswire) - Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences advanced technologies industries, has secured five prestigious awards at the esteemed Asia-Pacific Biopharma Excellence Awards (ABEA)2024.

Key Points: 
  • SINGAPORE, Mar 21, 2024 - (ACN Newswire) - Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences advanced technologies industries, has secured five prestigious awards at the esteemed Asia-Pacific Biopharma Excellence Awards (ABEA)2024.
  • Avantor sweeps 5 Biopharma Award at the Asia Pacific Biopharma Excellence Awards 2024 in Singapore.
  • "These awards are a testament to the dedication and expertise of our Avantor team," remarked Christophe Couturier, Executive Vice President of AMEA, Avantor.
  • The Asia-Pacific Biopharma Excellence Awards (ABEA) recognizes exceptional Asian bioprocessing, biologistic, clinical trials and aseptic fill and finish experts, organizations and technologies.

GERMAGIC(TM) PET Hosts "Social Inclusion Charity Run with Pets"

Retrieved on: 
Montag, März 18, 2024
Yee, Health, New Territories, Social, Certification, Social exclusion, Pet, Environment, Companion, City University, Business, PET, Life, SGS, Bacteria, Virus, APEL, Athlete, Human, Dog, Biochemistry, Love, QPP, Safety, Metro Broadcast Corporation, Cat, Creative industries

GERMAGIC(TM) PET is the title sponsor of the "Social Inclusion Charity Run with Pets" on 17 March.

Key Points: 
  • GERMAGIC(TM) PET is the title sponsor of the "Social Inclusion Charity Run with Pets" on 17 March.
  • To provide pets with more care and protection, GERMAGIC(TM) PET continuously innovates and utilizes its scientific research technology to develop various green pet health products, thus promoting social inclusion and sustainable development.
  • GERMAGIC(TM) PET products utilize GERMAGIC(TM)'s encapsulation technology and molecular materials to comprehensively support and protect pet health.
  • This certification not only recognizes the quality of GERMAGIC(TM) PET products but also sets higher quality standards for the pet health industry.

APEL Biomedical Technology Innovation and Translational Commercial Laboratory Officially Opens

Retrieved on: 
Mittwoch, März 13, 2024
Yee, New Territories, Nutrition, Health, Technology transfer, Quality of life, HKSAR, Hygiene, QPP, Corporation, Certification, Environment, Innovation, Biotechnology, Partnership, Biomedical technology, Biological engineering, Translational research, Silk, Knowledge, Research, SGS, Lifestar, Translation, Science park, Sustainability, Pet, Government, Growth, Greater, Perception, PET, HKSTP, APEL, Life, Hong Kong Science Park, Toxicology, Division, Medical imaging

Dr. Grace Lau, Head of Institute for Translational Research of Hong Kong Science and Technology Parks Corporation (HKSTP) stated, "It is great to see the official opening of APEL Laboratory and the successful transformation of scientific research and technology into commercial products.

Key Points: 
  • Dr. Grace Lau, Head of Institute for Translational Research of Hong Kong Science and Technology Parks Corporation (HKSTP) stated, "It is great to see the official opening of APEL Laboratory and the successful transformation of scientific research and technology into commercial products.
  • We have attracted numerous biomedical innovation and technology enterprises, covering areas such as pharmaceuticals, medical devices, diagnostics, and traditional Chinese medicine.
  • Today, we are delighted to have officially established our presence in Hong Kong Science Park with the opening of the Biomedical Technology Innovation and Translational Commercial Laboratory.
  • The pet industry ecosystem is vibrant, and today, during the inauguration ceremony of the APEL Biomedical Technology Innovation and Translational Commercial Laboratory, APEL also organized a panel discussion on the future opportunities and transformations in the pet industry.